Ironwood CFO Sravan Emany resigns effective Dec 18; CEO McCourt interim PFO

IRONWOOD PHARMACEUTICALS INC

Sravan Emany resigns as SVP, COO, and CFO effective Dec 18, 2024.
Resignation not due to any disagreement on financial reporting matters.
CEO Thomas McCourt will serve as interim principal financial officer.
Company will search for a new CFO; interim arrangement in place.

item 5.02

IRONWOOD PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001104659-24-125937

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.